- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01054521
A Randomized Study of Temperature-controlled and Bipolar Radiofrequency for Inferior Turbinate Reduction (CompareRFIT)
A Randomized Comparison Study of Temperature-controlled and Bipolar Radiofrequency for Inferior Turbinate Reduction in Patients With Chronic Rhinitis
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bangkok, Thailand, 10700
- Siriraj Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults with snoring and chronic nasal obstruction.
- Respond to topical decongestant but not respond to nasal steroids, oral anti-histamine and oral decongestant
- Consent to the protocol.
Exclusion Criteria:
- Chronic active sinusitis, severe Deviated nasal septum (DNS), nasal polyps, sinonasal tumor, previous sinonasal surgery or head neck irradiation.
- Uncontrolled bleeding disorders, hypertension, or cardiovascular diseases
- Not complete the protocol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Temperature-controlled RF (TCRF)
The temperature-controlled RF was done under local anesthesia (0.5% xylocaine with adrenaline 1:200,000 injection at both inferior turbinates.)
The RF probe will be inserted at inferior turbinate for 5 points both left and right nasal cavity (2 at anterior end, 2 at middle part and 1 at posterior end).
We apply energy of 300 J, 85 C, and 15 W each point.
After procedures the patients was observed at 1 hour before discharge without any packings.
|
The temperature-controlled RF was done under local anesthesia (0.5% xylocaine with adrenaline 1:200,000 injection at both inferior turbinates.) The RF probe will be inserted at inferior turbinate for 5 points both left and right nasal cavity (2 at anterior end, 2 at middle part and 1 at posterior end). We apply energy of 300 J, 85 C, and 15 W each point. After procedures the patients was observed at 1 hour before discharge without any packings. For nontemperature-controlled RF, the probe will be inserted at the same area with TCRF. We use 2.5 watt and 3 sec for each point but will stop immediately if the burning color or sound are detected. Otherwise was the same with TCRF.
Other Names:
|
|
Active Comparator: Bipolar RF (BRF)
The bipolar RF (BRF) probe will be inserted at the same area with TCRF.
We use 2.5 watt and 3 sec for each point but will stop immediately if the burning color or sound are detected.
Otherwise was the same with TCRF.
|
The bipolar RF probe will be inserted at the same area with TCRF.
The energy used will be 2.5 watt and 3 sec for each point but will stop immediately if the burning color or sound are detected.
Otherwise was the same with TCRF.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Visual Analog scale scores of nasal obstructive symptom.
Time Frame: Up to 1 year follow-up
|
Up to 1 year follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VAS scores of nasal discharge, sneezing, hyposmia, postnasal drip
Time Frame: Up to 1 year follow-up
|
Shor-term at 4th week and long-term at 1 year follow-up
|
Up to 1 year follow-up
|
|
Postoperative crust, mucociliary transportation time (MTT), minimal cross sectional area (MCA), total nasal volume (VOL), nasal airway resistance (NAR) at 75 Pa
Time Frame: Up to 1 year follow-up
|
Crusting was assessed at 1st week and 4th week, MTT at 4th week, and MCA, VOL, and NAR were assessed before and after treatment at 4th week and one year follow-up
|
Up to 1 year follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Wish Banhiran, MD, Mahidol University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- wbanhiran
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients With Chronic Rhinitis Who Failed Medical Treatment
-
Shandong Suncadia Medicine Co., Ltd.Not yet recruitingKRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard TreatmentChina
-
Fujian Cancer HospitalNot yet recruitingPatients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE
-
Yonsei UniversityWithdrawnPatients in the Treatment of Subjects With All-comer Who Are to Undergo PCI
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingAdult Patients With Chronic Primary ITP | Adult Patients With SAA Who do Not Respond Well to Immunosuppressive Therapy
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingAdult Patients With Chronic Primary ITP | Adult Patients With SAA Who do Not Respond Well to Immunosuppressive TherapyChina
-
Guiying WangNot yet recruitingPatients With Metastatic Colorectal Cancer Who Were TP53-mutant and LRPPRC-positive and Had Previously Failed Prior First-line Treatment
-
Novartis PharmaceuticalsCompletedPatients Successfully Completing the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPS
-
Zhejiang UniversityCNK Cell Therapeutics Co., Ltd.RecruitingPatients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard TreatmentsChina
-
University of FloridaEmergency Medicine FoundationCompletedED Patients With Chronic Medical IllnessesUnited States
-
Ron ScheyCompletedPatients With Gastroparesis Who Have Failed Standard TherapyUnited States
Clinical Trials on Temperature-controlled RF
-
Fudan UniversityCompleted
-
US Department of Veterans AffairsThe Alfred E. Mann Foundation for Scientific ResearchTerminatedStrokeUnited States
-
Heart Center Leipzig - University HospitalCompletedAtrial FibrillationGermany
-
Portsmouth Hospitals NHS TrustUniversity of OxfordCompleted
-
Airsonett ABKarolinska University Hospital; Quintiles, Inc.; University Hospital, LinkoepingCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingUreterolithiasis | Renal CalculiChina
-
Airsonett ABCommitum AB; Croel ABCompletedAsthmaDenmark, United Kingdom, Norway, Sweden, Germany, Finland
-
Imperial College LondonJP Moulton Charitable FoundationRecruitingAtopic Dermatitis EczemaUnited Kingdom
-
Peking University People's HospitalChinese Association of Plastics and AestheticsRecruitingPostmenopausal Vulvovaginal AtrophyChina